Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Brian Sullivan who wrote (1505)	1/19/2000 9:17:00 PM
From: Sam Citron	Read Replies (1) \| Respond to of 1754

Sent the following note to CBS Marketwatch writer, Brenon Daly. I think I will do without the Daly report from now on. Brenon, I am sure you work very hard under the pressure of deadlines, etc., but you missed by a mile on this one. VISX traded as low as 39 in afterhours. I was particularly sorry that you could no enlighten readers as to the cause of the disappointment, because earnings seemed to have matched consensus estimates. So you not only gave erroneous information but you missed the real story. You wrote: Visx said after the bell that it earned $25.8 million, or 38 cents per share, up from $17.2 million, or 26 cents, in the same period last year. That was in line with the First Call estimate. Sales at the laser company (VISX: news, msgs) rose 79 percent to $75.1 million. The stock closed off 1 3/8 at 45 3/8 *and held that level after hours.* [bold italics added for emphasis] cbs.marketwatch.com Regards, Sam Citron